- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Guerbet S.A.
Industry Sector: HealthTechnology
CEO: David Hale
Number Of Employees: 2,905
Enterprise Value: $705,220,399
PE Ratio: 15.95
Exchange/Ticker 1: Euronext Paris:GBT
Exchange/Ticker 2: N/A
Latest Market Cap: $287,644,940
BioCentury | Dec 19, 2019
Finance
Truffle’s recipe for company creation
Truffle Capital plans to deploy €250M fund to scour the U.S., Europe for IP to build biotechs, medtechs
BioCentury | Sep 25, 2019
Company News
Sept. 24 Company Quick Takes: FDA approves smallpox vaccine; plus Epidyolex, Vitrakvi, Oral semaglutide, Takeda-Evotec, Guerbet-IBM Watson
BioCentury | Jan 12, 2018
Financial News
Truffle Capital raises $102M toward life science and medtech fund
BioCentury | Jan 10, 2018
Financial News
Truffle Capital raises $102M toward life science and medtech fund
Items per page:
1 - 10 of 24